Showing results (111-120 of 242) with videos related to

Sort By:
Pageof 25
The American Journal of Pathology|May 10, 2002
CpG island methylation in aberrant crypt foci of the colorectumAnnie On-On Chan, Russell R Broaddus, Patrick S Houlihan, et al.
Gastroenterology|May 6, 2003
Epigenetic and genetic alterations in duodenal carcinomas are distinct from biliary and ampullary carcinomasSang Geol Kim, Annie On-On Chan, Tsung-Teh Wu, et al.
Cancer Research|August 18, 2010
Chromatin remodeling is required for gene reactivation after decitabine-mediated DNA hypomethylationJiali Si, Yanis A Boumber, Jingmin Shu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
Effect of cytarabine and decitabine in combination in human leukemic cell linesTaichun Qin, Emile M Youssef, Jaroslav Jelinek, et al.
Nucleic Acids Research|May 31, 2014
TET1 is a maintenance DNA demethylase that prevents methylation spreading in differentiated cellsChunlei Jin, Yue Lu, Jaroslav Jelinek, et al.
The Protein Journal|November 13, 2017
A Proteomics Analysis Reveals 9 Up-Regulated Proteins Associated with Altered Cell Signaling in Colon Cancer PatientsOleg I Kit, Dmitry I Vodolazhsky, Denis S Kutilin, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 8, 2018
Nerve Injury-Induced Chronic Pain Is Associated with Persistent DNA Methylation Reprogramming in Dorsal Root GanglionJudit Garriga, Geoffroy Laumet, Shao-Rui Chen, et al.
Cancer Biology & Therapy|March 21, 2007
Epigenetic inactivation of EGFR by CpG island hypermethylation in cancerAlberto J Montero, C Marcela Díaz-Montero, Li Mao, et al.
Chinese Journal of Cancer|March 29, 2011
Tumor-associated methylation of the putative tumor suppressor AJAP1 gene and association between decreased AJAP1 expression and shorter survival in patients with gliomaDavid Cogdell, Woonbok Chung, Yuexin Liu, et al.
Cancer Medicine|August 13, 2017
INST OX-05-024: first line gemcitabine, oxaliplatin, and erlotinib for primary hepatocellular carcinoma and bile duct cancers: a multicenter Phase II trialYehuda Z Patt, Waheed Murad, Mohammed H Fekrazad, et al.
Pageof 25